Blank Rome Represents QuVa Pharma in Acquisition of Assets of the 503B Compounding Pharmacy Services Division of Healix, Inc.
Blank Rome represented QuVa Pharma in its acquisition of the assets of the 503B Compounding Pharmacy Services Division of Healix, Inc., including its state-of-the-art manufacturing facility. QuVa Pharma has received a majority equity commitment from Bain Capital Private Equity, a leading global investment firm, to support the company’s creation and expansion plans.